Introduction
The research peptide landscape has expanded dramatically over the past decade. While hundreds of peptides are under investigation in preclinical and clinical settings, a core group of compounds consistently appears across the research literature as the most studied and cited. This overview identifies the ten most researched peptides as of 2025 based on publication volume, clinical trial activity, and research community interest.
1. Semaglutide
Semaglutide leads peptide research activity by almost any measure in 2025. As an approved GLP-1 receptor agonist for type 2 diabetes and obesity, it has generated thousands of clinical publications and is actively being studied in cardiovascular disease, kidney disease, liver disease, cognitive decline, and addiction research. Its commercial success has fueled an unprecedented level of research investment.
2. Tirzepatide
Tirzepatide, the dual GIP/GLP-1 receptor agonist, has rapidly accumulated a massive research profile following its approval and exceptional weight loss outcomes in clinical trials. Research is active across metabolic disease, cardiovascular risk reduction, and next-generation incretin combination approaches.
3. BPC-157
BPC-157 remains the most researched peptide in the musculoskeletal and gastrointestinal repair space. Its extensive rodent model literature, diverse proposed mechanisms, and growing interest in potential human applications keep it at the top of the preclinical research peptide list.
4. TB-500 (Thymosin Beta-4)
TB-500’s systemic tissue repair mechanisms and cardiac research applications maintain high research activity. Its role in the phase of early cardiac repair and wound healing research continues to generate new studies.
5. Retatrutide
The triple agonist Retatrutide — targeting GLP-1, GIP, and glucagon receptors simultaneously — generated significant research excitement following phase 2 trial results showing extraordinary weight loss. It is one of the most active areas of new peptide research in 2025.
6. PT-141 (Bremelanotide)
As an FDA-approved drug with a well-characterized melanocortin mechanism, PT-141 continues to be studied for extensions of its current indication and as a reference compound for MC4R biology research.
7. Epithalon
Telomere research and longevity science have driven sustained interest in Epithalon. Its telomerase activation data and animal longevity findings continue to attract researchers in aging biology.
8. IGF-1 LR3
IGF-1 LR3 remains a cornerstone of muscle biology, cell proliferation, and metabolic research. Its use as a cell culture supplement and in vivo research tool maintains consistent research activity across multiple disciplines.
9. Selank and Semax
The Russian neuropeptides Selank and Semax continue to attract growing Western research interest as nootropic and anxiolytic research compounds with established clinical approval histories in Russia and Ukraine.
10. CJC-1295 and Ipamorelin
The CJC-1295/Ipamorelin combination remains one of the most studied research pairings in growth hormone secretagogue research, maintaining its position as the reference GH axis stimulation protocol in preclinical studies.
Conclusion
The most researched peptides in 2025 reflect both the maturation of existing research programs and the emergence of new directions in metabolic, regenerative, and neurological peptide science. GLP-1 class compounds dominate by clinical volume while BPC-157, TB-500, and the neuropeptides lead preclinical research activity.